Inari medical director Hoffman sells over 1.8m in company stock
NARI Stock | USD 49.77 2.03 3.92% |
Under 54% of Inari Medical's investor base is interested to short. The analysis of overall sentiment of trading Inari Medical stock suggests that many investors are impartial at this time. Inari Medical's investing sentiment shows overall attitude of investors towards Inari Medical.
Inari |
Inari medical director Hoffman sells over 1.8m in company stock
Read at investing.com
Inari Medical Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Inari Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Inari Medical Maximum Pain Price Across January 17th 2025 Option Contracts
Inari Medical's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Inari Medical close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Inari Medical's options.
Inari Medical Fundamental Analysis
We analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Inari Medical is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Inari Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inari Medical stock to make a market-neutral strategy. Peer analysis of Inari Medical could also be used in its relative valuation, which is a method of valuing Inari Medical by comparing valuation metrics with similar companies.
Peers
Inari Medical Related Equities
OM | Outset Medical | 19.66 | ||||
LEGN | Legend Biotech | 3.02 | ||||
PGNY | Progyny | 0.73 |
Complementary Tools for Inari Stock analysis
When running Inari Medical's price analysis, check to measure Inari Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inari Medical is operating at the current time. Most of Inari Medical's value examination focuses on studying past and present price action to predict the probability of Inari Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inari Medical's price. Additionally, you may evaluate how the addition of Inari Medical to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Transaction History View history of all your transactions and understand their impact on performance |